An open label, dose titration study of sevelamer carbonate tablets dosed three times a day in hyperphosphatemic chronic kidney disease patients not on dialysis

Update Il y a 4 ans
Reference: EUCTR2005-003233-41

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

- Evaluate the efficacy of sevelamer carbonate tablets dosed three times a day (TID) with meals on control of serum phosphorus levels - Evaluate the safety and tolerability of sevelamer carbonate tablets dosed TID with meals


Inclusion criteria

  • chronic kidney disease